Related Experiment Video
Updated: Aug 2, 2026
08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
Microencapsulation of Leydig cells: a system for testosterone supplementation
Marcelle Machluf1, Anna Orsola, Stephen Boorjian
1Laboratory of Cellular Therapeutics and Tissue Engineering, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Endocrinology
|September 10, 2003
Summary
Microencapsulated Leydig cells offer a novel approach to testosterone supplementation for men experiencing age-related decline. This method successfully delivered testosterone in vivo, potentially overcoming limitations of traditional therapies.
Area of Science:
- Endocrinology
- Biotechnology
- Regenerative Medicine
Background:
- Testosterone decline in elderly men can cause bone loss, reduced muscle strength, and decreased libido.
- Current testosterone therapies have potential complications like fluid retention and hypertension.
- There is a need for physiological, long-acting androgen delivery systems.
Purpose of the Study:
- To investigate the efficacy of alginate-poly-L-lysine-encapsulated Leydig cell microspheres for testosterone delivery.
- To assess the in vivo testosterone secretion and stability of encapsulated Leydig cells.
Main Methods:
- Leydig cells were encapsulated in alginate-poly-L-lysine microspheres.
- Encapsulated cells were stimulated with human chorionic gonadotropin (hCG) in vitro.
- Microspheres were administered to castrated rats, and serum testosterone levels were monitored.
Main Results:
- Encapsulated Leydig cells secreted high testosterone levels in culture when stimulated with hCG.
- Unencapsulated cells failed to produce testosterone.
- Castrated rats receiving encapsulated cells maintained serum testosterone levels for up to 43 days.
Conclusions:
- Microencapsulated Leydig cells demonstrate potential as a viable therapeutic option for testosterone supplementation.
- This novel delivery system may offer a more physiological and sustained method for androgen replacement.
- Further research could lead to improved treatments for conditions associated with low testosterone.
